Buchumschlag

Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Ruoyuan Qian, Biqing Yang, Xinyi Xu, Bo Lu
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Statistics in Medicine
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials
von: Daniel E. Schwartz, et al.
Veröffentlicht: (2026)

The Cox Model With Adaptive Fused Group Bridge Penalty to Incorporate Historical Data Into the Analysis of Clinical Trials With an Application to BMT CTN 1101
von: Xi Fang, et al.
Veröffentlicht: (2025)

RMST for Interval‐Censored Data in Oncology Clinical Trials
von: Xiyuan Gao, et al.
Veröffentlicht: (2025)

Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring
von: Shu Jiang, et al.
Veröffentlicht: (2025)

Modern Causal Inference Approaches to Improve Power for Subgroup Analysis in Randomized Controlled Trials
von: Antonio D'Alessandro, et al.
Veröffentlicht: (2026)

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
von: Jingya Gao, et al.
Veröffentlicht: (2024)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
von: Yuwei Cheng, et al.
Veröffentlicht: (2026)

Bayesian Random‐Effects Meta‐Analysis of Aggregate Data on Clinical Events
von: Christian Röver, et al.
Veröffentlicht: (2026)

Bayesian Power Prior in Platform Trials With Non‐Concurrent Control for Binary Outcomes: Development and Comparative Evaluation
von: Junichi Asano, et al.
Veröffentlicht: (2026)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
von: Xiaotian Chen, et al.
Veröffentlicht: (2025)

MARGO: Machine Learning‐Assisted Adaptive Randomization for Group Sequential Trials Based on Overlap Weights
von: Yeonhee Park, et al.
Veröffentlicht: (2025)

Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials
von: Godwin Yung, et al.
Veröffentlicht: (2025)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
von: Yunyi Liu, et al.
Veröffentlicht: (2026)

Futility Monitoring in Clinical Trials
von: Ana M. Ortega‐Villa, et al.
Veröffentlicht: (2025)

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
von: Hyejung Jung, et al.
Veröffentlicht: (2026)

Analysis of Stepped‐Wedge Cluster Randomized Trials: A Tutorial Using Marginal Models
von: Elizabeth L. Turner, et al.
Veröffentlicht: (2026)

Powerful Test of Heterogeneity in Two‐Sample Summary‐Data Mendelian Randomization
von: Kai Wang, et al.
Veröffentlicht: (2024)

Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout
von: Analissa Avila, et al.
Veröffentlicht: (2025)

A Framework for Generating Realistic Synthetic Tabular Data in a Randomized Controlled Trial Setting
von: Niki Z. Petrakos, et al.
Veröffentlicht: (2025)

An Augmented Likelihood Approach Incorporating Error‐Prone Auxiliary Data Into a Survival Analysis
von: Noorie Hyun, et al.
Veröffentlicht: (2025)

Model‐Robust Standardization in Cluster‐Randomized Trials
von: Fan Li, et al.
Veröffentlicht: (2025)

Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling
von: Alessandro Gasparini, et al.
Veröffentlicht: (2025)

Comments on “Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods”
von: M. C. Donohue, et al.
Veröffentlicht: (2025)

Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data
von: Guoqiao Wang, et al.
Veröffentlicht: (2024)

Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials
von: Jiaqi Tong, et al.
Veröffentlicht: (2025)

Correction to “Model‐Robust Standardization in Cluster‐Randomized Trials”
Veröffentlicht: (2026)

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials
von: Hao Wang, et al.
Veröffentlicht: (2026)

Time‐Varying Treatment Effect Models in Stepped‐Wedge Cluster‐Randomized Trials With Multiple Interventions
von: Zhe Chen, et al.
Veröffentlicht: (2026)

Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
von: Ethan Ashby, et al.
Veröffentlicht: (2025)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
von: Liwen Wu, et al.
Veröffentlicht: (2025)

Testing for Similarity of Dose Response in Multiregional Clinical Trials
von: Holger Dette, et al.
Veröffentlicht: (2025)

An Empirical Assessment of the Cost of Dichotomization of the Outcome of Clinical Trials
von: Erik W. van Zwet, et al.
Veröffentlicht: (2026)

Patient‐Centric Pragmatic Clinical Trials: Opening the DOOR
von: Scott R. Evans, et al.
Veröffentlicht: (2026)

A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien–Wei–Lachin
von: Guangyong Zou, et al.
Veröffentlicht: (2024)

Response to Letter to the Editor “Comments on ‘Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods’”
von: Guoqiao Wang, et al.
Veröffentlicht: (2025)

Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials
von: Marco Ratta, et al.
Veröffentlicht: (2026)

Semiparametric Estimation of Relative Causal Effects in Randomized Controlled Trials With Noncompliance
von: Wenli Liu, et al.
Veröffentlicht: (2025)

Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
von: Maria Vittoria Chiaruttini, et al.
Veröffentlicht: (2026)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
von: Alessandra Serra, et al.
Veröffentlicht: (2025)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
von: Gi‐Ming Wang, et al.
Veröffentlicht: (2026)